Sumampao, Julhana U.
HRN: 20-08-70 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/13/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/13/2022
05/19/2022
IVTT
200mg
Q6
Pcap C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes